Article

Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Sanquin Research, and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands.
Blood Cells Molecules and Diseases (Impact Factor: 2.33). 10/2010; 45(3):246-65. DOI: 10.1016/j.bcmd.2010.07.012
Source: PubMed

ABSTRACT Chronic granulomatous disease (CGD) is an immunodeficiency disorder affecting about 1 in 250,000 individuals. The disease is caused by a lack of superoxide production by the leukocyte enzyme NADPH oxidase. Superoxide is used to kill phagocytosed micro-organisms in neutrophils, eosinophils, monocytes and macrophages. The leukocyte NADPH oxidase is composed of five subunits, of which the enzymatic component is gp91-phox, also called Nox2. This protein is encoded by the CYBB gene on the X chromosome. Mutations in this gene are found in about 70% of all CGD patients. This article lists all mutations identified in CYBB in the X-linked form of CGD. Moreover, apparently benign polymorphisms in CYBB are also given, which should facilitate the recognition of future disease-causing mutations.

0 Followers
 · 
420 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic granulomatous disease (CGD) is an inherited orphan disorder caused by mutations in one of the five genes encoding reduced nicotinamide-adenine-dinucleotide-phosphate oxidase subunits, which subsequently lead to impairment in the production of microbicidal reactive oxygen species (ROS). In order to offer several cell line models of CGD and therefore support research on pathophysiology and new therapeutic approaches, we optimized protocols to differentiate induced pluripotent stem cells (iPSCs) from wild-type, X 0 -, AR22 0 -and AR47 0 -CGD patient's fibroblasts into neutrophils and into macrophages. Aberrant genetic clones were dis-carded after chromosome karyotyping and array-comparative genomic hybridization analysis. All remaining iPSC lines showed human embryonic stem cell–like morphology, expressed all tested pluripotency markers and formed embryoid bodies that contained cells originating from all three primary germ layers. Furthermore, each CGD patient-specific iPSC line retained the gp91 phox , p47 phox , and p22 phox mutations found in the corre-sponding patient's neutrophils. The average production of CD34 + progenitors was of 1.5 · 10 6 cells after 10 days of differentiation of 10 · 10 6 iPSCs. They were terminally differentiated into about 3 · 10 5 neutrophils or into 3 · 10 7 macrophages. Based on morphological, phenotypical, and functional criteria both phagocyte types were mature and indistinguishable from the native human neutrophils and macrophages. However, neutrophils and macrophages derived from X 0 -, AR22 0 -, and AR47 0 -CGD patient-specific iPSC lines lacked ROS produc-tion and the corresponding mutated proteins. To simplify the phagocytes' production upon request, progenitors can be cryopreserved. In conclusion, we describe a reproducible, simple, and efficient way to generate neutro-phils and macrophages from iPSCs and provide a new cellular model for the AR22 0 -CGD genetic form that has not been described before.
    12/2014; 3(6). DOI:10.1089/biores.2014.0045
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Staphylococcus aureus (S. aureus) is a common pathogen found in the community and in hospitals. Most notably, Methicillin-resistant S. aureus is resistant to many antibiotics, which is a growing public health concern. The emergence of drug-resistant strains has prompted the search for alternative treatments such as immunotherapeutic approaches. To date, most clinical trials of vaccines or passive immunization against S. aureus have ended in failure. In this study, we investigated two ESAT-6-like proteins secreted by S. aureus, SaEsxA and SaEsxB, as possible targets for a vaccine. Mice vaccinated with these purified proteins elicited high titers of anti-SaEsxA and anti-SaEsxB antibodies, but these antibodies could not prevent S. aureus infection. On the other hand, rSaEsxA and rSaEsxB could induce Th1- and Th17-biased immune responses in mice. Mice immunized with rSaEsxA and rSaEsxB had significantly improved survival rates when challenged with S. aureus compared with the controls. These findings indicate that SaEsxA and SaEsxB are two promising Th1 and Th17 candidate antigens, which could be developed into multivalent and serotype-independent vaccines against S. aureus infection.
    Infection and Immunity 12/2015; 83(Number 1):339-345. DOI:10.1128/IAI.02498-14 · 4.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Neutrophils, the most abundant human immune cells, are rapidly recruited to sites of infection, where they fulfill their life-saving antimicrobial functions. While traditionally regarded as short-lived phagocytes, recent findings on long-term survival, neutrophil extracellular trap (NET) formation, heterogeneity and plasticity, suppressive functions, and tissue injury have expanded our understanding of their diverse role in infection and inflammation. This review summarises our current understanding of neutrophils in host-pathogen interactions and disease involvement, illustrating the versatility and plasticity of the neutrophil, moving between host defence, immune modulation, and tissue damage.
    PLoS Pathogens 03/2015; 11(3):e1004651. DOI:10.1371/journal.ppat.1004651 · 8.06 Impact Factor

Full-text (4 Sources)

Download
275 Downloads
Available from
Jun 4, 2014